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Abstract Neuronal phospholipase D (PLD) activity was
hypothesized to be involved in vesicle trafficking and endocytosis
and, possibly, transmitter release. We here report that prolonged
depolarization of rat hippocampal slices by potassium chloride
(KCl) or 4-aminopyridine inhibited PLD activity. Similarly,
PLD activity in rat cortical synaptosomes was significantly
inhibited by depolarizing agents including veratridine and
ouabain. Inhibition of calcium/calmodulin kinase II (CaMKII)
which positively modulates synaptosomal PLD activity [Sarri et
al. (1998) FEBS Lett. 440, 287^290] by KN-62 caused a further
reduction of PLD activity in depolarized synaptosomes. Depo-
larization-induced inhibition of PLD activity was apparently not
due to transmitter release or activation of other kinases. We
observed, however, that KCl-induced depolarization caused an
increase of inositol phosphates and a reduction of the synapto-
somal pool of phosphatidylinositol-4,5-bisphosphate (PIP2).
Moreover, in synaptosomes permeabilized with Staphylococcus
aureus K-toxin, PLD activation induced by calcium was
abolished by neomycin, a PIP2 chelator. We conclude that
depolarizing conditions cause an inhibition of neuronal PLD
activity which is likely due to breakdown of PIP2, a required
cofactor for PLD activity. Our findings suggest that neuronal
PLD activity is regulated by synaptic activity.
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1. Introduction
The phospholipases D (PLD), a group of enzymes catalyz-
ing the hydrolysis of phosphatidylcholine to phosphatidic acid
and choline, have attracted much interest in neurochemistry
because they are activated by a variety of neurotransmitters
and other factors in neural tissue [1] ; for instance, hippocam-
pal PLD activity is enhanced by glutamate in an age-depend-
ent manner [2]. Recent molecular studies have identi¢ed sev-
eral PLD isoforms and some pathways of activation for these
enzymes [3,4]. At least two isoforms of PLD are present in
mammalian tissues, one of which (PLD1) can be activated by
interaction with protein kinase C (PKC) K or L and small G
proteins of the ARF and Rho families [5]. In contrast, PLD2
seems to have a high basal activity and may be regulated by
inhibitory interactions with other proteins [6]. Both isoforms
require phosphatidylinositol-4,5-bisphosphate (PIP2) as a co-
factor for enzymatic activity.
The physiological role of PLD in nervous tissue is a matter
of speculation. While a role for PLD in membrane tra⁄cking,
protein transport, and cytoskeletal organization has been
clearly shown in leukocytes and ¢broblasts [3], the claim for
a role of PLD in neurosecretion so far relies on indirect evi-
dence [7]. A recent report described ARF translocation and
PLD activation in stimulated chroma⁄n cells suggesting a
role for PLD in exocytosis [8] ; however, others could not
reproduce these ¢ndings [9]. Studies in synaptosomes demon-
strated PLD activity in presynaptic nerve endings which could
be stimulated by phorbol esters and, in the presence of
GTPQS, by muscarinic agonists [10,11]. We have previously
used permeabilized synaptosomes to show that synaptosomal
PLD is activated by an increase of intracellular calcium (from
0.1 to 1 WM); this response was apparently mediated by cal-
cium/calmodulin kinase II (CaMKII) but not by protein ki-
nase C [12]. In the present communication, we describe the
modulation of neuronal PLD activity in hippocampal slices
and in synaptosomes under depolarizing conditions.
2. Materials and methods
2.1. Materials
Radioactive compounds ([3H]glycerol, [3H]myristate, [3H]inositol)
were from DuPont NEN (Dreieich, Germany), kinase inhibitors
from Calbiochem (Bad Soden, Germany), and bu¡er salts from
Merck (Darmstadt, Germany). All other chemicals were obtained
from Sigma (Deisenhofen, Germany). Staphylococcus aureus K-toxin
was prepared as previously described [13]. Ro 31-8220 was kindly
provided by Dr. D. Bradshaw, Roche Research Centre, Welwyn Gar-
den City, Hertfordshire, England.
2.2. PLD activity in hippocampal slices
Hippocampal slices (400 Wm) were prepared from adult Wistar rats,
superfused at 35‡C with carbogen-gassed Krebs-Henseleit bu¡er
(KHB; 116 mM NaCl, 25 mM NaHCO3, 1.2 mM NaH2PO4, 7.1
mM KCl, 1.2 mM MgSO4, 1.2 mM CaCl2, 11.7 mM glucose, pH
7.4) and labeled by incubation with 40 WCi [3H]glycerol for 2 h. After
a 30 min wash, the superfusion medium was changed to KHB con-
taining di¡erent concentrations of KCl or 4-aminopyridine and prop-
anol (2%). When the KCl concentration was elevated, the NaCl con-
centration was reduced accordingly. After 30 min, the slices were
extracted, the major phospholipids were separated by TLC, and
[3H]phosphatidylpropanol (PP) was identi¢ed using internal standards
as described before [2]. The radioactivity associated with PP was
counted and expressed as % of radioactivity present in the lipid phase.
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2.3. PLD activity in synaptosomes
Synaptosomes were prepared essentially as described previously
[12]. Cortices from two adult Wistar rats were homogenized in 0.32
M sucrose containing 1 mM Na,Ca-EDTA and 0.25 mM dithiothrei-
tol (pH 7.4) and centrifuged at 1000Ug for 10 min, and the super-
natants were layered on top of a Percoll gradient (3, 10 and 23%) in
the same sucrose solution. After centrifugation for 5 min at 32 500Ug,
the fraction containing synaptosomes (between 10 and 23% Percoll)
was recovered and washed twice in KHB.
Synaptosomes from two rats were labeled with [3H]myristic acid (40
WCi, 2 h) in carbogen-gassed KHB, washed and incubated at 37‡C by
adding 100 Wl of synaptosomes (0.3^0.5 mg protein) to glass tubes
containing KHB, drugs, and 1% (v/v) ethanol (¢nal volume: 250 Wl).
Kinase inhibitors were added in DMSO (¢nal concentration: 0.1% or
less). After 30 min, 1.2 ml of chloroform/methanol (1:2, v/v) were
added and, after lipid extraction, the phospholipids were separated
by two-dimensional TLC, scraped and the radioactivity determined
as described [12]. The formation of [3H]phosphatidylethanol (PEth)
was expressed as % of radioactivity present in [3H]phosphatidyl-
choline (PC).
For experiments with calcium and neomycin, synaptosomes were
permeabilized as described before [12]. Brie£y, synaptosomes were
washed in potassium glutamate bu¡er (KG bu¡er) which contained
150 mM potassium glutamate, 20 mM PIPES, 2 mM ATP, 3 mM
EGTA, and 6 mM MgCl2 (pH 6.8). Synaptosomes (3^5 mg/ml of
protein) were exposed to 100 Wg/ml of S. aureus K-toxin (15 min,
37‡C); thereafter, PLD activity was measured as described above in
synaptosomes which were incubated in KG bu¡er containing an ele-
vated calcium concentration (15 WM) and/or neomycin.
2.4. Determinations of inositol phosphates and phosphatidylinositols
Synaptosomes were prelabeled for 2 h with 30^50 WCi of
[3H]inositol in calcium-free KHB. After washing, 100 Wl of synapto-
somes (0.3^0.5 mg protein) were incubated in KHB containing 7 or 30
mM KCl. After 30 min, the reaction was stopped by adding 1.2 ml
chloroform/methanol (1:2, v/v). After the addition of 0.5 ml of
chloroform and 0.5 ml 0.5 M HCl, the upper (aqueous) phase was
used to determine the formation of total [3H]inositol phosphates as
described previously [12]. For the determination of phosphoinositides,
the lower (lipid) phase was washed and a phosphoinositide standard
mixture was added. Then, the lipid phase was evaporated to dryness,
taken up in chloroform/methanol (2:1) and separated by TLC on
oxalate-precoated plates. The eluent was chloroform/methanol/3.3 M
ammonia (43:38:12). Phosphatidylinositol (PI) and phosphatidylino-
sitol-4,5-bisphosphate (PIP2) were identi¢ed by staining with iodine,
extracted, and the radioactivity determined in a scintillation counter.
PIP2 levels were calculated as [% PIP2/PI].
3. Results and discussion
3.1. E¡ects of depolarizing agents on phospholipase D activity
in hippocampal slices
The present study was stimulated by our observation that
hippocampal PLD activity was a¡ected under depolarizing
conditions. As illustrated in Fig. 1, elevation of the KCl con-
centration from 3 to 30 mM caused an inhibition of basal
PLD activity in a concentration-dependent manner. Maximal
inhibition (336%; P6 0.01) was seen at 30 mM KCl corre-
sponding to a membrane potential of 342 mV as calculated
from the Nernst equation; at higher KCl concentrations (50^
100 mM) PLD activity was increased again (not illustrated).
At 30 mM KCl, PLD inhibition was also seen when the in-
cubation times were 10 or 60 min (data not shown). In sepa-
rate experiments, hippocampal PLD activity was also reduced
by 4-aminopyridine (4-AP), a compound which depolarizes
cells by blocking potassium channels [14]; signi¢cant inhibi-
tory e¡ects were seen with 500 WM 4-AP (331%; N = 5,
P6 0.05) and 5 mM 4-AP (342%; N = 6, P6 0.01).
3.2. E¡ects of depolarizing agents and neurotransmitters on
PLD activity in synaptosomes
To test whether the depolarization-induced inhibition of
PLD activity was a presynaptic response, we determined
Fig. 1. Phospholipase D activity in hippocampal slices: e¡ects of
KCl-induced depolarization. Basal PLD activity was determined in
the presence of varying concentrations of KCl from the formation
of [3H]phosphatidylpropanol (PP) in % of the radioactivity associ-
ated with the lipid phase. Data are means þ S.E.M. of 8^12 experi-
ments. *, P6 0.05 and **, P6 0.01 vs. control (KHB, 7.1 mM
KCl).
Fig. 2. Phospholipase D activity in synaptosomes. (A) E¡ects of de-
polarizing agents. (B) E¡ects of kinase inhibitors. Rat cortical syn-
aptosomes were labeled with [3H]myristate and incubated in KHB
bu¡er containing 1% ethanol. For (A), KCl (30 mM, NaCl re-
duced), veratridine (Vera; 100 WM), 4-aminopyridine (4-AP; 5 mM),
or ouabain (Oua; 1 mM) were present. For (B), 1 WM Ro 31-8220
(Ro) or KN-62 were present under control conditions (Ctr, KHB)
or in the presence of KCl (30 mM). PLD activity is given as forma-
tion of [3H]phosphatidylethanol (PEth) in % of [3H]PC. Data are
means þ S.E.M. from 4^8 experiments. Statistical signi¢cance: (A) *,
P6 0.05; **, P6 0.01 vs. control. (B) *, P6 0.05; **, P6 0.01 vs.
control (KHB). The PLD activity measured in the presence of 30
mM KCl and 1 WM KN-62 was also signi¢cantly lower (P6 0.01)
than the PLD activity measured with 30 mM KCl alone.
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PLD activities in synaptosomes. As shown in Fig. 2A, a sig-
ni¢cant inhibition of synaptosomal PLD activity was seen
under four di¡erent conditions of chemically induced depola-
rization including exposure to KCl, 4-AP, veratridine, a so-
dium channel opener, and ouabain, an inhibitor of Na/K
ATPase [15]. The inhibition of synaptosomal PLD activity by
30 mM KCl (333%, P6 0.01) was similar as that seen in
hippocampal slices (Fig. 1A).
We then investigated whether depolarization-induced re-
lease of neurotransmitters could be involved in the PLD re-
sponse. Previous studies had reported activations of neuronal
PLD by acetylcholine [11] and glutamate [2]. However, in the
present experiments, synaptosomal PLD activity was not af-
fected by the muscarinic agonist carbachol (1 WM^1 mM) or
by acetylcholine (10 WM), both in the presence or absence of
neostigmine (10 WM) (data not shown). Glutamate (10 WM^1
mM) was also inactive, even in the presence of glutamate
uptake inhibitors such as arachidonic acid (10 WM) or
L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC, 1 mM). More-
over, PLD activity was not signi¢cantly a¡ected by aluminum
£uoride (10 WM), a broad-spectrum activator of trimeric G
proteins. Finally, the lack of e¡ects of forskolin (30 WM),
dibutyryl-cAMP and dibutyryl-cGMP (100 WM each in the
presence of 30 WM digitonin) excluded a cross-talk between
adenylate and guanylate cyclases and PLD (data not shown).
3.3. Inhibition of synaptosomal PLD under depolarizing
conditions: role of kinases
We had previously reported that synaptosomal PLD activ-
ity is increased by elevation of cytosolic calcium [12] ; this
e¡ect was inhibited by 1 WM KN-62, a speci¢c inhibitor of
CaMKII [16]. In the present experiments, we tested the e¡ect
of KN-62 on basal and KCl-evoked PLD activity. Impor-
tantly, the inhibitory e¡ect of KCl-induced depolarization
was strongly enhanced in the presence of KN-62 (1 WM;
Fig. 2B); basal PLD activity was not a¡ected. Moreover,
the KCl-induced inhibition of synaptosomal PLD activity in
these experiments (320%, P6 0.05) was also strongly intensi-
¢ed in the presence of the calmodulin antagonists W-7
(348 þ 3%, N = 5) and tri£uoperazine (337 þ 3%, N = 5),
each at 10 WM (not illustrated). Thus, a pronounced inhibi-
tory in£uence of depolarization on synaptosomal PLD activ-
ity is revealed when the calmodulin-dependent, PLD-activat-
ing pathway is blocked.
In separate experiments, we also tested a possible role of
protein kinase C (PKC) in PLD regulation. 4L-Phorbol-
12K,13L-diacetate (PDB; 0.1 WM), a PKC activator, signi¢-
cantly stimulated synaptosomal PLD activity; this stimulation
was seen both under basal conditions (+95%; P6 0.01) and
under depolarizing conditions (30 mM KCl) (+73%; P6 0.01)
(not illustrated). 4L-Phorbol-13K-acetate (0.1 WM), an inactive
phorbol ester, did not a¡ect PLD activity (data not shown).
Ro 31-8220 (1 WM), a cell-permeable PKC inhibitor [17], po-
tently reduced the PDB-induced PLD activation (by 66%;
P6 0.01; not illustrated) but did not signi¢cantly a¡ect the
KCl-induced inhibition of PLD activity (Fig. 2B). These ¢nd-
ings exclude a participation of PKC in the regulation of PLD
activity during depolarization.
3.4. Inhibition of synaptosomal PLD under depolarizing
conditions: role of PIP2 breakdown
What could be the mechanism of the depolarization-in-
duced inhibition of PLD activity? As both isozymes of PLD
require PIP2 as a cofactor for enzymatic activity, we focussed
on the hypothesis that reductions of the synaptosomal levels
of PIP2 might be responsible for the observed e¡ects. In agree-
ment with previous work [18], we found that depolarization of
synaptosomes (30 mM KCl, 30 min) which were prelabeled
with [3H]inositol signi¢cantly enhanced the synaptic levels of
inositol phosphates from 16.2 þ 0.7 to 21.4 þ 1.3% of total ino-
sitol label (N = 4; P6 0.05) (not illustrated). Importantly, we
also found that the synaptosomal levels of PIP2 were signi¢-
cantly reduced after 10^30 min of exposure to 30 mM KCl
(Fig. 3A); concomitantly, PLD activity was inhibited in a
mirror-like manner (Fig. 3B). In separate experiments, we
found that incubation of synaptosomes with 4-AP (5 mM)
also caused a signi¢cant reduction of synaptosomal PIP2 lev-
els (322%; N = 6, P6 0.01). These data, in particular the
Fig. 3. E¡ects of depolarization (30 mM KCl, 10 or 30 min) on (A)
synaptosomal level of phosphatidylinositol-4,5-bisphosphate (PIP2)
and (B) synaptosomal PLD activity. In (A), PIP2 levels are ex-
pressed as % [3H]PIP2 of [3H]PI. In (B), PLD activity is given as
formation of [3H]phosphatidylethanol (PEth) in % of [3H]PC. Data
are means þ S.E.M. from four experiments run in parallel. Statistical
signi¢cance: *, P6 0.05; **, P6 0.01 vs. control.
Fig. 4. E¡ects of neomycin on basal and calcium-stimulated PLD
activity in synaptosomes. Permeabilized synaptosomes were incu-
bated in KG bu¡er containing 1% ethanol and 0.1 or 15 WM calci-
um, and neomycin (Neo; 0.1 and 1 mM). PLD activity is given as
formation of [3H]phosphatidylethanol (PEth) in % of [3H]PC; data
are means þ S.E.M. from 6^7 experiments. Statistical signi¢cance:
**, P6 0.01 vs. control (Ca2, 15 WM, no neomycin).
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parallel decrease of synaptosomal PIP2 levels and PLD activ-
ity after KCl depolarization (Fig. 3), are compatible with the
hypothesis that PIP2 breakdown may be responsible for the
inhibition of PLD activity under depolarizing conditions.
To further substantiate this idea, we carried out experi-
ments with neomycin, an aminoglycoside antibiotic which is
known to complex PIP2 and to interfere with its biological
activities including PLD activation [19,20]. As neomycin, a
highly basic compound, does not penetrate cellular mem-
branes, the synaptosomes had to be permeabilized with S.
aureus K-toxin, a 33 kDa protein which forms a hydrophilic
pore of small diameter in synaptosomes, thereby allowing the
passage of small molecules [12,21]. Under this condition, syn-
aptosomal PLD can be activated by increases of the free cal-
cium concentration [12]. In the present experiments, PLD ac-
tivations induced by elevated calcium were signi¢cantly
inhibited by 0.1 mM neomycin and completely abolished by
1 mM neomycin (Fig. 4). In contrast, basal PLD activities
were only slightly a¡ected by these neomycin concentrations.
This ¢nding documents an essential role of PIP2 for synapto-
somal PLD activity under calcium-stimulated conditions.
3.5. Conclusion
Summarizing, the present work demonstrates for the ¢rst
time that, in rat hippocampal slices and cortical synapto-
somes, neuronal PLD activity can be inhibited by chemically
induced depolarization. This unexpected ¢nding suggests that
neuronal PLD activity may be regulated by synaptic activity
and is compatible with a role of PLD in synaptic function.
From the experiments with CaMKII inhibitors we conclude
that this inhibition of PLD activity occurs in parallel to an-
other, PLD-activating signalling pathway which we previously
described [12] to involve calcium in£ux and CaMKII activa-
tion; further experiments must show whether these two path-
ways target di¡erent PLD isoenzymes or di¡erent pools of the
same isoform. The mechanism of PLD inhibition apparently
involves PIP2 breakdown. We report that depolarization is
accompanied by a reduction of the synaptosomal PIP2 level,
and this reduction of PIP2 may be an important factor limit-
ing PLD activation as shown by the experiments with neo-
mycin; in fact, our results suggest that PIP2 availability may
be rate-limiting for PLD activation [22]. PIP2 breakdown was
likely initiated by the calcium-dependent activation of a syn-
aptosomal phospholipase C, a process which is prominent in
excitable tissues [23]. Alternatively, synaptosomal PIP2 levels
may be reduced by 5-phosphatases such as synaptojanin
which was recently shown to interact with PLD [24]; however,
synaptojanin activity is not known to be modulated by depo-
larization, and the concomitant formation of inositol phos-
phates reported above favors a role for a phospholipase C-
mediated mechanism.
The present ¢ndings give some hints as to the functional
role of synaptosomal, PIP2-dependent PLD. In synaptic nerve
endings, phosphoinositides are important regulators of exo-
and endocytotic vesicle tra⁄c, and they occur in at least
two separate pools, one in the plasma membrane and another
pool associated with the cytoskeleton [25,26]. We cannot spec-
ulate on a role for PLD in rapid processes of exocytosis since,
in our experiments, an inhibition of PLD activity was found
on a time-scale of 10^30 min. However, PLD activity is asso-
ciated with the cytoskeleton, and a role for PLD in the mobi-
lization of a reserve pool of synaptic vesicles or endocytosis of
vesicles from the plasma membrane can be envisaged; these
processes occur on a time-scale of seconds to minutes [27]
which are compatible with measurable changes of PLD activ-
ity, e.g. in hippocampal slices [2]. Future experiments should
concentrate on the relationship of PLD isoforms with speci¢c
pools of PIP2 in synaptic nerve endings.
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